Symbols / HYPD Stock $4.17 +6.11% Hyperion DeFi, Inc.

Healthcare • Biotechnology • United States • NCM
HYPD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Hyunsu Jung
Exch · Country NCM · United States
Market Cap 47.50M
Enterprise Value 49.57M
Income -47.00M
Sales 813.46K
FCF (ttm) -9.05M
Book/sh 4.73
Cash/sh 0.57
Employees 9
Insider 10d —
IPO Jan 25, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 58.40
P/B 0.88
P/C —
EV/EBITDA -2.84
EV/Sales 60.94
Quick Ratio 2.48
Current Ratio 2.68
Debt/Eq 20.74
LT Debt/Eq —
EPS (ttm) -9.40
EPS next Y —
EPS Growth —
Revenue Growth 16.66%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-15
Earnings (prior) 2026-03-26
ROA -41.89%
ROE -3.24%
ROIC —
Gross Margin 62.72%
Oper. Margin -36.09%
Profit Margin 0.00%
Shs Outstand 11.39M
Shs Float 9.67M
Insider Own 17.50%
Instit Own 11.67%
Short Float 10.30%
Short Ratio 2.93
Short Interest 1.12M
52W High 17.18
vs 52W High -75.73%
52W Low 1.02
vs 52W Low 308.82%
Beta 2.63
Impl. Vol. —
Rel Volume 0.58
Avg Volume 396.67K
Volume 228.29K
Target (mean) $6.28
Tgt Median $6.28
Tgt Low $4.30
Tgt High $8.25
# Analysts 2
Recom None
Prev Close $3.93
Price $4.17
Change 6.11%
About

Hyperion DeFi, Inc., operates as a digital asset treasury and ophthalmic technology company in the United States. The company is a U.S. publicly listed company building a long-term strategic treasury of HYPE tokens to provide shareholders with simplified exposure to the Hyperliquid blockchain ecosystem, while also developing the Optejet ophthalmic microdose mist delivery system and related topical ocular therapies. It operates through two segments: Ophthalmic Technology and Digital Assets. The Ophthalmic Technology segment focuses on the development and planned registration of the Optejet Ocular User Filled Device, designed for horizontal, microdose spray delivery of ophthalmic liquids such as artificial tears and lens rewetting products, aiming to improve administration accuracy, patient comfort, and compliance in chronic front-of-the-eye conditions. The Digital Assets segment is engaged in acquiring, holding, and managing a reserve of HYPE and other digital assets, including on-chain activities such as validating and DeFi partnerships, staking and related treasury strategies. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.28
Mean price target
2. Current target
$4.17
Latest analyst target
3. DCF / Fair value
$-14.29
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.17
Low
$4.30
High
$8.25
Mean
$6.28

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-27 main Chardan Capital Buy → Buy $8
2025-12-24 init Chardan Capital — → Buy $8
2025-12-16 init Cantor Fitzgerald — → Overweight $4
2025-03-21 reit HC Wainwright & Co. Neutral → Neutral $2
2025-02-06 reit HC Wainwright & Co. Neutral → Neutral $2
News
RSS: Latest HYPD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-12 RUBENSTEIN ROBERT General Counsel — 75,000 $0.00 $0
2025-12-31 KNOX DAVID R Chief Financial Officer — 27,950 $3.59 $100,340
2025-12-29 STRAHLMAN ELLEN Director — 30,880 $3.60 $113,091
2025-12-18 STRAHLMAN ELLEN Director — 38,444 $3.14 $120,664
2025-12-17 GELTZEILER MICHAEL S Director — 30,000 $3.01 $90,210
2025-12-17 WALTERS HAPPY DAVID Director — 61,930 $3.02 $187,152
2025-09-29 KNOX DAVID R Chief Financial Officer — 300,000 $0.00 $0
2025-09-08 WALTERS HAPPY DAVID Director — 50,000 $0.00 $0
2025-08-18 GELTZEILER MICHAEL S Director — 50,000 $0.00 $0
2025-08-18 STRAHLMAN ELLEN Director — 50,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.81
+1318.75%
0.06
+1414.02%
0.00
0.00
Operating Revenue
0.81
+1318.75%
0.06
+1414.02%
0.00
0.00
Cost Of Revenue
0.30
-92.28%
3.93
+24437.51%
0.02
0.00
Reconciled Cost Of Revenue
0.30
-92.28%
3.93
+24437.51%
0.02
0.00
Gross Profit
0.51
+113.18%
-3.87
-31573.69%
-0.01
0.00
Operating Expense
19.49
-42.09%
33.66
+32.55%
25.39
-5.64%
26.91
Research And Development
1.91
-86.79%
14.46
+11.46%
12.98
-3.01%
13.38
Selling General And Administration
17.18
+19.83%
14.33
+15.42%
12.42
-8.24%
13.53
Selling And Marketing Expense
—
0.75
-31.90%
1.10
-8.84%
1.20
General And Administrative Expense
17.18
+19.83%
14.33
+26.61%
11.32
-8.18%
12.33
Salaries And Wages
—
6.72
+11.23%
6.04
-2.56%
6.20
Other Gand A
17.18
+19.83%
14.33
+229.57%
4.35
-14.23%
5.07
Other Operating Expenses
—
4.86
—
—
Total Expenses
19.79
-47.34%
37.59
+47.92%
25.41
-5.58%
26.91
Operating Income
-18.98
+49.42%
-37.53
-47.72%
-25.41
+5.59%
-26.91
Total Operating Income As Reported
-46.72
+4.14%
-48.74
-91.83%
-25.41
+5.59%
-26.91
EBITDA
-43.76
+5.30%
-46.21
-91.68%
-24.11
+8.42%
-26.32
Normalized EBITDA
-18.35
+49.36%
-36.24
-50.33%
-24.11
+8.42%
-26.32
Reconciled Depreciation
0.00
-100.00%
1.13
+44.08%
0.78
+154.76%
0.31
EBIT
-43.76
+7.56%
-47.33
-90.18%
-24.89
+6.54%
-26.63
Total Unusual Items
-25.41
-154.89%
-9.97
0.00
0.00
Total Unusual Items Excluding Goodwill
-25.41
-154.89%
-9.97
0.00
0.00
Special Income Charges
-25.56
-156.47%
-9.97
0.00
0.00
Other Special Charges
-2.33
—
—
—
Impairment Of Capital Assets
27.19
+142.59%
11.21
0.00
—
Restructuring And Mergern Acquisition
0.00
+100.00%
-1.24
0.00
—
Write Off
9.03
0.00
—
—
Net Income
-45.31
+9.04%
-49.82
-82.75%
-27.26
+2.68%
-28.01
Pretax Income
-45.31
+9.04%
-49.82
-82.75%
-27.26
+2.68%
-28.01
Net Non Operating Interest Income Expense
-1.32
+40.92%
-2.23
-32.90%
-1.68
-29.42%
-1.30
Interest Expense Non Operating
1.56
-37.30%
2.48
+4.75%
2.37
+71.87%
1.38
Net Interest Income
-1.32
+40.92%
-2.23
-32.90%
-1.68
-29.42%
-1.30
Interest Expense
1.56
-37.30%
2.48
+4.75%
2.37
+71.87%
1.38
Interest Income Non Operating
0.24
-5.51%
0.25
-63.38%
0.69
+732.41%
0.08
Interest Income
0.24
-5.51%
0.25
-63.38%
0.69
+732.41%
0.08
Other Income Expense
-25.02
-148.72%
-10.06
-5601.29%
-0.18
-189.51%
0.20
Other Non Operating Income Expenses
0.39
+530.11%
-0.09
+48.64%
-0.18
-189.51%
0.20
Gain On Sale Of Security
0.16
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
-0.02
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-45.31
+9.04%
-49.82
-82.75%
-27.26
+2.68%
-28.01
Net Income From Continuing Operation Net Minority Interest
-45.31
+9.04%
-49.82
-82.75%
-27.26
+2.68%
-28.01
Net Income From Continuing And Discontinued Operation
-45.31
+9.04%
-49.82
-82.75%
-27.26
+2.68%
-28.01
Net Income Continuous Operations
-45.31
+9.04%
-49.82
-82.75%
-27.26
+2.68%
-28.01
Normalized Income
-19.93
+50.00%
-39.85
-46.18%
-27.26
+2.68%
-28.01
Net Income Common Stockholders
-47.00
+5.66%
-49.82
-82.75%
-27.26
+2.68%
-28.01
Diluted EPS
—
-59.81
-12.53%
-53.15
+19.95%
-66.40
Basic EPS
—
-59.81
-12.53%
-53.15
+19.95%
-66.40
Basic Average Shares
—
0.83
+62.41%
0.51
+21.94%
0.42
Diluted Average Shares
—
0.83
+62.41%
0.51
+21.94%
0.42
Diluted NI Availto Com Stockholders
-47.00
+5.66%
-49.82
-82.75%
-27.26
+2.68%
-28.01
Gain On Sale Of PPE
8.32
0.00
—
—
Insurance And Claims
—
0.85
-8.56%
0.93
-12.08%
1.06
Preferred Stock Dividends
1.68
—
—
—
Provision For Doubtful Accounts
0.41
0.00
—
—
Line Item Trend 2025-12-31 2023-12-31
Total Assets
51.76
+79.87%
28.78
Current Assets
7.25
-65.01%
20.71
Cash Cash Equivalents And Short Term Investments
6.44
-56.61%
14.85
Cash And Cash Equivalents
6.44
-56.61%
14.85
Receivables
0.26
-58.03%
0.62
Other Receivables
—
0.12
Taxes Receivable
0.26
-47.65%
0.50
Inventory
—
0.11
Raw Materials
—
0.08
Work In Process
—
0.00
Finished Goods
—
0.03
Prepaid Assets
0.34
-60.92%
0.87
Current Deferred Assets
—
4.26
Other Current Assets
0.20
—
Total Non Current Assets
44.52
+451.47%
8.07
Net PPE
0.42
-92.77%
5.75
Gross PPE
0.42
-94.20%
7.17
Accumulated Depreciation
—
-1.42
Properties
—
0.00
Construction In Progress
—
0.71
Other Properties
0.42
-91.16%
4.71
Leases
—
1.75
Goodwill And Other Intangible Assets
36.94
+1639.89%
2.12
Other Intangible Assets
36.94
+1639.89%
2.12
Non Current Accounts Receivable
6.94
—
Non Current Prepaid Assets
0.23
+16.86%
0.20
Other Non Current Assets
—
—
Total Liabilities Net Minority Interest
10.70
-45.89%
19.78
Current Liabilities
2.70
-71.66%
9.53
Payables And Accrued Expenses
1.82
-23.76%
2.39
Payables
1.30
-26.78%
1.78
Accounts Payable
0.32
-81.87%
1.75
Other Payable
—
0.03
Dividends Payable
0.79
—
Current Accrued Expenses
0.52
-14.91%
0.61
Pensionand Other Post Retirement Benefit Plans Current
0.19
-85.36%
1.30
Total Tax Payable
0.19
—
Current Debt And Capital Lease Obligation
0.51
-91.22%
5.83
Current Debt
—
5.33
Other Current Borrowings
—
5.33
Current Capital Lease Obligation
0.51
+2.15%
0.50
Current Deferred Liabilities
—
—
Other Current Liabilities
0.18
+2158.43%
0.01
Total Non Current Liabilities Net Minority Interest
8.00
-21.92%
10.25
Long Term Debt And Capital Lease Obligation
8.00
-21.92%
10.25
Long Term Debt
7.80
-12.96%
8.96
Long Term Capital Lease Obligation
0.21
-84.02%
1.29
Non Current Deferred Liabilities
—
—
Stockholders Equity
41.06
+356.27%
9.00
Common Stock Equity
41.06
+356.27%
9.00
Capital Stock
0.00
+2391.23%
0.00
Common Stock
0.00
+1436.84%
0.00
Preferred Stock
0.00
—
Share Issued
8.76
+1438.84%
0.57
Ordinary Shares Number
8.68
+1424.38%
0.57
Treasury Shares Number
0.08
0.00
Additional Paid In Capital
281.94
+82.49%
154.49
Retained Earnings
-240.62
-65.39%
-145.49
Treasury Stock
0.25
—
Total Equity Gross Minority Interest
41.06
+356.27%
9.00
Total Capitalization
48.86
+172.09%
17.96
Working Capital
4.54
-59.34%
11.18
Invested Capital
48.86
+109.81%
23.29
Total Debt
8.51
-47.05%
16.08
Net Debt
1.35
—
Capital Lease Obligations
0.72
-59.94%
1.79
Net Tangible Assets
4.12
-40.03%
6.88
Tangible Book Value
4.12
-40.04%
6.88
Interest Payable
—
—
Preferred Stock Equity
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-14.77
+50.96%
-30.12
-26.36%
-23.84
+5.05%
-25.11
Cash Flow From Continuing Operating Activities
-14.77
+50.96%
-30.12
-26.36%
-23.84
+5.05%
-25.11
Net Income From Continuing Operations
-45.31
+9.04%
-49.82
-82.75%
-27.26
+2.68%
-28.01
Depreciation Amortization Depletion
0.00
-100.00%
1.13
+44.08%
0.78
+154.76%
0.31
Depreciation
0.00
-100.00%
1.13
+44.08%
0.78
+154.76%
0.31
Depreciation And Amortization
0.00
-100.00%
1.13
+44.08%
0.78
+154.76%
0.31
Other Non Cash Items
-1.22
-141.80%
2.91
+140.36%
1.21
+36.59%
0.89
Stock Based Compensation
6.37
+273.88%
1.70
-31.77%
2.50
-33.66%
3.77
Provisionand Write Offof Assets
0.41
0.00
-100.00%
0.40
0.00
Asset Impairment Charge
27.19
+90.22%
14.29
+116885.98%
0.01
-94.16%
0.21
Operating Gains Losses
0.71
—
—
—
Gain Loss On Sale Of PPE
-8.32
0.00
—
0.00
Change In Working Capital
-2.91
-757.33%
-0.34
+77.04%
-1.48
+34.60%
-2.26
Change In Receivables
0.00
-100.00%
0.10
-90.66%
1.06
+70.61%
0.62
Change In Inventory
—
0.00
+100.00%
-0.12
0.00
Change In Prepaid Assets
-0.20
-136.87%
0.56
+27.45%
0.44
+215.47%
0.14
Change In Payables And Accrued Expense
-2.13
-1494.96%
0.15
+1470.86%
0.01
+101.84%
-0.53
Change In Accrued Expense
-0.50
-69.54%
-0.29
+6.84%
-0.32
+8.02%
-0.34
Change In Payable
-1.64
-466.50%
0.45
+37.46%
0.32
+274.84%
-0.19
Change In Account Payable
-1.64
-466.50%
0.45
+37.46%
0.32
+274.84%
-0.19
Change In Other Working Capital
—
-0.65
+72.63%
-2.36
-13.41%
-2.08
Change In Other Current Liabilities
-0.57
-14.53%
-0.50
+0.36%
-0.50
-21.96%
-0.41
Investing Cash Flow
-71.95
-44459.93%
-0.16
+95.93%
-3.97
-353.91%
-0.87
Cash Flow From Continuing Investing Activities
-71.95
-44459.93%
-0.16
+95.93%
-3.97
-353.91%
-0.87
Net PPE Purchase And Sale
0.00
+100.00%
-0.16
+94.33%
-2.85
-225.53%
-0.87
Purchase Of PPE
0.00
+100.00%
-0.16
+94.33%
-2.85
-225.53%
-0.87
Capital Expenditure
-71.95
-44459.93%
-0.16
+95.93%
-3.97
-353.91%
-0.87
Net Intangibles Purchase And Sale
-71.95
0.00
+100.00%
-1.12
0.00
Purchase Of Intangibles
-71.95
0.00
+100.00%
-1.12
0.00
Financing Cash Flow
91.05
+418.64%
17.55
-11.31%
19.79
-7.97%
21.51
Cash Flow From Continuing Financing Activities
91.05
+418.64%
17.55
-11.31%
19.79
-7.97%
21.51
Net Issuance Payments Of Debt
-1.46
+73.42%
-5.51
-225.38%
4.39
+140.64%
1.82
Issuance Of Debt
—
0.00
-100.00%
5.00
-50.00%
10.00
Repayment Of Debt
-1.46
+73.42%
-5.51
-803.74%
-0.61
+92.55%
-8.18
Long Term Debt Issuance
—
0.00
-100.00%
5.00
-50.00%
10.00
Long Term Debt Payments
-1.46
+73.42%
-5.51
-803.74%
-0.61
+92.55%
-8.18
Net Long Term Debt Issuance
-1.46
+73.42%
-5.51
-225.38%
4.39
+140.64%
1.82
Net Common Stock Issuance
40.65
+58.65%
25.62
+53.31%
16.71
-18.19%
20.43
Cash Dividends Paid
-0.89
0.00
—
—
Proceeds From Stock Option Exercised
4.82
+393622.24%
0.00
-97.54%
0.05
+165.92%
0.02
Net Other Financing Charges
47.94
+1972.18%
-2.56
-88.38%
-1.36
-78.18%
-0.76
Changes In Cash
4.32
+133.96%
-12.73
-58.81%
-8.01
-79.16%
-4.47
Beginning Cash Position
2.12
-85.71%
14.85
-35.05%
22.86
-16.36%
27.34
End Cash Position
6.44
+203.73%
2.12
-85.71%
14.85
-35.05%
22.86
Free Cash Flow
-86.72
-186.38%
-30.28
-8.90%
-27.81
-7.03%
-25.98
Interest Paid Supplemental Data
0.48
-70.33%
1.62
-4.03%
1.69
+435.75%
0.32
Income Tax Paid Supplemental Data
0.00
0.00
—
—
Common Stock Issuance
40.65
+58.65%
25.62
+53.31%
16.71
-18.19%
20.43
Issuance Of Capital Stock
40.65
+58.65%
25.62
+53.31%
16.71
-18.19%
20.43
Preferred Stock Dividend Paid
-0.89
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category